摘要
The first session of the appraisal campaign, which lasted seven months, for choosing ten top "foreign-funded" pharmaceutical enterprises nationwide concluded on June 21. The State Pharmaceutical AdminiStration issued award certificates to the ten "foreign-funded" pharmaceutical enterprises which had won the honour of the best ten title headed by Xian-Janssen Pharmaceutical Ltd. This is the first large scale comprehensive appraisal of business scale, economic results and product status of the "foreign-funded" pharmaceutical enterprises all over China, aiming
